Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ZCMD
stocks logo

ZCMD

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Zhongchao Inc (ZCMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Zhongchao Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

ZCMD News & Events

Events Timeline

Sign Up For More Events
no data image
No Data
Sign Up For More Events

News

[object Object]
Preview
2.0
10-02NASDAQ.COM
ZCMD, ABCL, VOR, IXHL, OVID, BFRG Surge in After-Hours Trading Due to Clinical Progress and Recent Developments

  • Biotech Stocks Surge: Several biotech and healthcare stocks experienced significant after-hours gains on October 1, driven by technical momentum and recent clinical updates, despite the absence of new filings or press releases.

  • Zhongchao Inc. and AbCellera Biologics: Zhongchao Inc. saw a 14.04% increase after hours, while AbCellera Biologics rose 11.41%, both benefiting from prior trial data and analyst commentary rather than new announcements.

  • Vor Biopharma and Incannex Healthcare: Vor Biopharma rebounded 9.53% after a previous drop, and Incannex Healthcare gained 6.48%, with both companies relying on earlier clinical trial results to influence trading.

  • Ovid Therapeutics and Bullfrog AI Holdings: Ovid Therapeutics shares rose 8.03% following a positive earnings report, while Bullfrog AI Holdings advanced 3.44% after announcing an expansion of its sales and marketing team.

[object Object]
Preview
9.5
06-12Benzinga
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

  • Oracle Corporation Financial Results: Oracle's shares rose 7.6% in pre-market trading after reporting fourth-quarter revenue of $15.9 billion and adjusted earnings of $1.70 per share, both exceeding analyst expectations.

  • Pre-Market Stock Movements: Several stocks experienced significant changes in pre-market trading, with Healthcare Triangle, Inc. surging 141.3% and Intensity Therapeutics, Inc. plummeting 47.7% following their respective announcements.

[object Object]
Preview
2.0
2024-10-01Benzinga
What's Going On With Zhongchao Stock Today?

  • Zhongchao Inc. Stock Surge: Zhongchao Inc. (ZCMD) shares are experiencing a significant increase, up 56.1% to $2.10, as investors react positively to new stimulus measures from China, which include lower interest rates and relaxed mortgage regulations.

  • Market Activity and Trading Options: Over 30 million shares of Zhongchao have been traded, highlighting strong market interest, and potential investors can buy fractional shares through brokerage accounts or explore options trading for shorting the stock.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Zhongchao Inc (ZCMD) stock price today?

The current price of ZCMD is 0.6084 USD — it has increased 1.5 % in the last trading day.

arrow icon

What is Zhongchao Inc (ZCMD)'s business?

Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.

arrow icon

What is the price predicton of ZCMD Stock?

Wall Street analysts forecast ZCMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZCMD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Zhongchao Inc (ZCMD)'s revenue for the last quarter?

Zhongchao Inc revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Zhongchao Inc (ZCMD)'s earnings per share (EPS) for the last quarter?

Zhongchao Inc. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Zhongchao Inc (ZCMD)'s fundamentals?

The market is revising No Change the revenue expectations for ZCMD for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -35.96%.
arrow icon

How many employees does Zhongchao Inc (ZCMD). have?

Zhongchao Inc (ZCMD) has 111 emplpoyees as of December 05 2025.

arrow icon

What is Zhongchao Inc (ZCMD) market cap?

Today ZCMD has the market capitalization of 18.71M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free